contact
|
site map
|
careers
Home
About Us
Overview
Executive Team
Collaborations
Advisors
Pipeline
Overview
Compounds
Additional Programs
Clinical Trials
Families
Overview
Autism
Fragile X Syndrome
Resources
Join Mailing List
Our Science
Overview
mGluR5 pathway
GABA-B pathway
Publications
News & Events
News
Events
Video
Join Mailing List
Home
› Site map
Site Map
Primary links
Home
About Us
Overview
Executive Team
Collaborations
Advisors
Pipeline
Overview
Compounds
Additional Programs
Clinical Trials
Phase 3 Study of STX209 for Social Withdrawal in Fragile X Syndrome (Ages 5-11)
Phase 3 Study of STX209 for Social Withdrawal in Fragile X Syndrome (Ages 12-50)
Phase 2b Study of STX209 for Social Withdrawal in Autism Spectrum Disorders (Ages 5-21)
Families
Overview
Autism
Fragile X Syndrome
Resources
Join Mailing List
Our Science
Overview
mGluR5 pathway
mGluR5 pathway technical primer
GABA-B pathway
Publications
Autism and Obesity
News & Events
News
Events
Video
Join Mailing List
Latest News